Latest Articles
Knowledge is power. Get all the information you need to get on track – and stay there.
Weight-loss medications
The Wegovy pill: what it is, how it works, and when it’s coming to the UK
The Wegovy pill (oral semaglutide 25 mg) is the first GLP-1 pill approved for weight loss. FDA-approved in the U.S., UK approved in June 2026.
Weight-loss medications
Oral weight-loss medications in the UK: a 2026 guide to the Wegovy pill, Foundayo, and Rybelsus
Three oral GLP-1 weight-loss pills compared. Wegovy pill (13.6%) and Foundayo (11.2%) expected in UK late 2026 and 2027; Rybelsus available now for type 2.
Vegetarian/vegan
Hasselback halloumi bake
A vegetarian recipe with red pepper, cherry tomatoes, and tin chopped tomatoes. Ready in 60 mins. Serves 4. Developed by Second Nature dietitians.
Sides, sauces and dips
Herby feta quinoa bowl
A vegetarian side with uncooked quinoa, rocket, and spinach. Ready in 30 mins. Serves 4. Developed by Second Nature dietitians.
Lamb
Lamb pilaf
A gluten-free lamb recipe with lamb mince, carrots, and ras el hanout seasoning. Ready in 40 mins. Serves 4. Developed by Second Nature dietitians.
Sides, sauces and dips
Prawn cocktail
A gluten-free side with prawns, avocado, and little gem lettuces. Ready in under 15 mins. Serves 2. Developed by Second Nature dietitians.
Breakfast and eggs
Chorizo breakfast bowl
A gluten-free breakfast with corn on the cob, vine cherry tomatoes, and cauliflower rice. Ready in 30 mins. Serves 2. Developed by Second Nature.
Current Health
Why people on Mounjaro and Wegovy face stigma that ’dieters’ don’t
New research finds GLP-1 users are judged more harshly than dieters, and sometimes more than people who haven't lost weight. Here's what the study shows.
Weight-loss medications
Retatrutide vs Wegovy: which works better for weight loss?
Retatrutide produced 28.7% weight loss in trials vs Wegovy 7.2 mg's 20.7%. Retatrutide isn't UK-approved yet; Wegovy is the current option.
Weight-loss medications
Retatrutide side effects: what the trials show and how to manage them
Retatrutide's main side effects in trials: nausea (43%), heart rate increase of ~6.7 bpm, and dysesthesia (20.9%) at the 12 mg dose. Not yet UK-approved.
As seen on
As seen on
